Notice of Correction to Eligibility Information in RFA-AG-19-010 "Alzheimer Centers for Discovery of New Medicines (U54 Clinical Trial Not Allowed)"

Notice Number: NOT-AG-18-025

Key Dates
Release Date: August 10, 2018

Related Announcements
RFA-AG-19-010

Issued by
National Institute on Aging (NIA)

Purpose

The purpose of this Notice is to correct the eligibility information in RFA-AG-19-010 "Alzheimer Centers for Discovery of New Medicines (U54)."

The following changes have been made:

Part 2. Full Text of Announcement, Section III. Eligibility Information, 1. Eligible Applicants, Foreign Institutions

Currently reads:
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Corrected to read:
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Lorenzo Refolo, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-594-7576
Email: refolol@nia.nih.gov